Omada Health Statistics
Total Valuation
Omada Health has a market cap or net worth of $736.39 million. The enterprise value is $493.24 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omada Health has 62.04 million shares outstanding. The number of shares has increased by 161.89% in one year.
| Current Share Class | 62.04M |
| Shares Outstanding | 62.04M |
| Shares Change (YoY) | +161.89% |
| Shares Change (QoQ) | +4.96% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 91.69% |
| Float | 56.19M |
Valuation Ratios
The trailing PE ratio is 52.63 and the forward PE ratio is 17.29.
| PE Ratio | 52.63 |
| Forward PE | 17.29 |
| PS Ratio | 2.21 |
| Forward PS | 1.87 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | 26.16 |
| P/OCF Ratio | 25.67 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 37.69, with an EV/FCF ratio of 17.52.
| EV / Earnings | 35.15 |
| EV / Sales | 1.48 |
| EV / EBITDA | 37.69 |
| EV / EBIT | 71.81 |
| EV / FCF | 17.52 |
Financial Position
The company has a current ratio of 4.18, with zero debt.
| Current Ratio | 4.18 |
| Quick Ratio | 3.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 22.37 |
Financial Efficiency
Return on equity (ROE) is 5.72% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | 5.72% |
| Return on Assets (ROA) | 1.35% |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | 2.51% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $339,832 |
| Profits Per Employee | $14,320 |
| Employee Count | 980 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 24.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -37.89% |
| 50-Day Moving Average | 18.47 |
| 200-Day Moving Average | 17.70 |
| Relative Strength Index (RSI) | 22.56 |
| Average Volume (20 Days) | 1,414,556 |
Short Selling Information
The latest short interest is 9.16 million, so 14.77% of the outstanding shares have been sold short.
| Short Interest | 9.16M |
| Short Previous Month | 8.35M |
| Short % of Shares Out | 14.77% |
| Short % of Float | 16.31% |
| Short Ratio (days to cover) | 8.32 |
Income Statement
In the last 12 months, Omada Health had revenue of $333.04 million and earned $14.03 million in profits. Earnings per share was $0.23.
| Revenue | 333.04M |
| Gross Profit | 235.42M |
| Operating Income | 6.87M |
| Pretax Income | 14.03M |
| Net Income | 14.03M |
| EBITDA | 13.09M |
| EBIT | 6.87M |
| Earnings Per Share (EPS) | $0.23 |
Full Income Statement Balance Sheet
The company has $243.15 million in cash and no debt, with a net cash position of $243.15 million or $3.92 per share.
| Cash & Cash Equivalents | 243.15M |
| Total Debt | n/a |
| Net Cash | 243.15M |
| Net Cash Per Share | $3.92 |
| Equity (Book Value) | 273.16M |
| Book Value Per Share | 4.41 |
| Working Capital | 239.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $28.69 million and capital expenditures -$541,000, giving a free cash flow of $28.15 million.
| Operating Cash Flow | 28.69M |
| Capital Expenditures | -541,000 |
| Depreciation & Amortization | 6.22M |
| Net Borrowing | n/a |
| Free Cash Flow | 28.15M |
| FCF Per Share | $0.45 |
Full Cash Flow Statement Margins
Gross margin is 70.69%, with operating and profit margins of 2.06% and 4.21%.
| Gross Margin | 70.69% |
| Operating Margin | 2.06% |
| Pretax Margin | 4.21% |
| Profit Margin | 4.21% |
| EBITDA Margin | 3.93% |
| EBIT Margin | 2.06% |
| FCF Margin | 8.45% |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -161.89% |
| Shareholder Yield | -161.89% |
| Earnings Yield | 1.90% |
| FCF Yield | 3.82% |
Analyst Forecast
The average price target for Omada Health is $26.50, which is 123.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.50 |
| Price Target Difference | 123.25% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 23.24% |
| EPS Growth Forecast (3Y) | 84.56% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of 8.56 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.56 |
| Piotroski F-Score | 6 |